Original Research
Published on 06 Dec 2024
Real-world efficacy and safety of combined first-line treatment with PARP inhibitors and novel hormonal therapy in mCRPC patients with HRR gene mutations
- 1,999 views
Original Research
Published on 06 Dec 2024
Editorial
Published on 05 Dec 2024
Original Research
Published on 05 Dec 2024
Original Research
Published on 05 Dec 2024
Original Research
Published on 05 Dec 2024
Case Report
Published on 05 Dec 2024
Correction
Published on 04 Dec 2024
Original Research
Published on 04 Dec 2024
Case Report
Published on 04 Dec 2024
Original Research
Published on 04 Dec 2024
Original Research
Published on 04 Dec 2024
Brief Research Report
Published on 04 Dec 2024
Methods
Published on 04 Dec 2024
Original Research
Published on 03 Dec 2024
Original Research
Published on 02 Dec 2024
Original Research
Published on 02 Dec 2024
Editorial
Published on 02 Dec 2024
Original Research
Published on 02 Dec 2024
Original Research
Published on 02 Dec 2024
Original Research
Published on 02 Dec 2024
Original Research
Published on 29 Nov 2024
Systematic Review
Published on 29 Nov 2024
Review
Published on 29 Nov 2024
Brief Research Report
Published on 29 Nov 2024